In vitro screening of the library enables identification of functionally active Pept-ins, which we subsequently characterize, optimize and test in vivo
From the chosen APRs, we generate a library of Pept-ins
Our algorithm determines the most promising APR sequences are chosen for Pept-in design
We identify and analyze the APR sequences of the target protein
Physiological insights of the disease indication inform selection of the target
